Go Deep
Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,839 | -149.3 | 1.00 | 1.97 | 1,298.15 |
| Oct 2026 | 17,538 | -155.3 | 1.04 | 1.97 | 1,338.45 |
| Oct 2026 | 18,559 | -153.9 | 1.03 | 1.97 | 1,318.99 |
| Oct 2026 | 18,756 | -146.4 | 0.98 | 1.97 | 1,250.93 |
| Oct 2026 | 18,654 | -150.3 | 1.01 | 1.97 | 1,284.82 |
| Oct 2026 | 18,748 | -146.8 | 0.98 | 1.97 | 1,251.18 |
| Oct 2026 | 18,678 | -149.4 | 1.00 | 1.97 | 1,275.28 |
| Oct 2026 | 18,713 | -148.1 | 0.99 | 1.97 | 1,263.90 |
| Oct 2026 | 19,149 | -131.6 | 0.88 | 1.97 | 1,119.85 |
| Oct 2026 | 21,071 | 72.5 | 0.92 | 1.97 | 1,163.37 |
Integra LifeSciences Holdings Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 418,761,000.0 | 391,918,000.0 | 434,925,000.0 | 402,062,000.0 |
| Net Profit | 4,482,000.0 | -4,617,000.0 | -1,704,000.0 | -5,404,000.0 |
| EPS | 0.1 | -0.1 | -0.0 | -0.1 |
Integra LifeSciences Holdings Corporation Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 1,635,245,000.0 | 1,610,527,000.0 | 1,541,573,000.0 | 1,557,666,000.0 | — |
| Net Profit | -516,474,000.0 | -6,944,000.0 | 67,741,000.0 | 180,550,000.0 | — |
| EPS | -6.6 | -0.1 | 0.9 | 2.2 | — |
Integra LifeSciences Holdings Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 3,602,001,000.0 | 4,037,424,000.0 | 3,781,988,000.0 | 3,889,758,000.0 | — |
| Total Liabilities | 2,558,538,000.0 | 2,492,144,000.0 | 2,194,104,000.0 | 2,085,355,000.0 | — |
| Total Equity | 1,043,463,000.0 | 1,545,280,000.0 | 1,587,884,000.0 | 1,804,403,000.0 | — |
Owes vs Owns
Integra LifeSciences Holdings Corporation owed $0.71 for every $1 it owned in Jun 2026, up from $0.54 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.71× | 0.71× | 0.62× | 0.58× | 0.54× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Integra LifeSciences Holdings Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 7.3%Receivables 7.7%Inventory 13.7%Fixed assets (tangible) 16.2%Intangible assets 48.6%Other assets 6.4%
How it's funded — Dec 2025
Short-term debt 3.5%Long-term debt 48.0%Payables 2.7%Other liabilities 16.8%Shareholders' equity 29.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 263.7 | 273.6 | 309.1 | 456.7 |
| Receivables | 278.8 | 272.4 | 259.3 | 263.5 |
| Inventory | 492.7 | 429.1 | 389.6 | 324.6 |
| Fixed assets (tangible) | 584.9 | 549.8 | 496.4 | 459.6 |
| Intangible assets | 1,749.8 | 2,304.5 | 2,123.3 | 2,165.5 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 232.0 | 208.1 | 204.3 | 220.0 |
| Liabilities & equity | ||||
| Short-term debt | 126.5 | 607.1 | 14.5 | 38.1 |
| Long-term debt | 1,729.6 | 1,196.0 | 1,485.0 | 1,405.2 |
| Payables | 95.7 | 82.5 | 92.3 | 102.1 |
| Other liabilities | 606.7 | 606.5 | 602.2 | 539.9 |
| Shareholders' equity | 1,043.5 | 1,545.3 | 1,587.9 | 1,804.4 |
| Net tangible assets | -706.4 | -759.3 | -535.4 | -361.1 |
Integra LifeSciences Holdings Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 50,384,000.0 | 129,382,000.0 | 139,955,000.0 | 264,469,000.0 | — |
| Investing Activities | -108,063,000.0 | -390,808,000.0 | -94,178,000.0 | -58,580,000.0 | — |
| Financing Activities | 28,335,000.0 | 237,863,000.0 | -229,925,000.0 | -251,953,000.0 | — |